Sign In
Buy BMO
$165.21
+2.88 (+1.77%)
At Close: Jun 04, 2026
London Metal Exchange approves Bank of Montreal as member
08:30am, Tuesday, 14'th Jan 2025
The London Metal Exchange (LME) has approved Bank of Montreal (BMO) as a category 2 member, the exchange said on Tuesday.
Gold's role as a dynamic hedge will drive prices above $2,850 this year - BMO Capital Markets
02:46pm, Monday, 13'th Jan 2025
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include cover
BMO and Canal Road Group Form Strategic Partnership Aimed at Providing Direct Lending to Upper Middle-Market Companies
09:00am, Friday, 10'th Jan 2025
NEW YORK , Jan. 10, 2025 /PRNewswire/ - BMO (NYSE: BMO) and Canal Road Group ("CRG") today announced they are entering into a strategic partnership. As part of the arrangement, BMO's commitment to CR
Bank of Montreal Enters into Automatic Securities Purchase Plan
08:00am, Friday, 10'th Jan 2025
TORONTO , Jan. 10, 2025 /PRNewswire/ - Bank of Montreal (TSX: BMO) (NYSE: BMO) today announced that it has entered into an automatic securities purchase plan ("ASPP") with its broker, BMO Nesbi
Under Armour is an under-appreciated retail stock, says BMO's Simeon Siegel
11:15am, Tuesday, 31'st Dec 2024
Simeon Siegel, BMO Capital Markets analyst, joins 'Squawk on the Street' to discuss the potential risks for the retail sector.
Pharma has value names, but it's not a top pick for 2025, says BMO's Evan Siegerman
03:45pm, Monday, 23'rd Dec 2024
Evan Siegerman, BMO biotech analyst, joins 'Power Lunch' to discuss the big winners in the pharmaceutical space in 2025.
BMO's Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints
05:44pm, Friday, 20'th Dec 2024
Evan David Seigerman, BMO managing director, joins 'Fast Money' to discuss Novo sinking on its obesity drug data.
Pfizer's 2025 guidance positions company for EPS expansion, says BMO
02:34pm, Tuesday, 17'th Dec 2024
BMO Capital reiterated an Outperform rating and $36 price target on Pfizer, saying that 2025 guidance succeeds in meeting the majority of the firm's expectations outlined in its preview, positioning t
Gold is the brightest star in 2025, silver remains in second place - BMO Capital Markets
02:28pm, Tuesday, 17'th Dec 2024
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include cover
BMO's Brian Belski weighs in on UnitedHealth
04:03pm, Tuesday, 10'th Dec 2024
Brian Belski, BMO Capital Markets chief investment strategist, joins CNBC's 'Closing Bell' to discuss outlooks on healthcare, whether the shooting of UnitedHealthcare CEO Brian Thompson poses long-ter
BMO Q4 Earnings Dip, Stock Up on Projection of Fall in 2025 Provision
09:31am, Monday, 09'th Dec 2024
Higher provisions and a fall in NII hurt Bank of Montreal's fiscal Q4 earnings. Shares jump 8.5% on expectations of moderating provisions in fiscal 2025.
New Strong Sell Stocks for December 6th
04:55am, Friday, 06'th Dec 2024
AM, AVT and BMO have been added to the Zacks Rank #5 (Strong Sell) List on December 6, 2024.
Bank of Montreal: Higher Credit Risks And A Higher Dividend
02:30pm, Thursday, 05'th Dec 2024
Bank of Montreal's business growth is strong, but rising credit loss provisions have significantly pressured profits, leading to a cautious outlook. The bank's net interest income grew by 10%, driven
Bank of Montreal (BMO) Q4 2024 Earnings Call Transcript
11:28am, Thursday, 05'th Dec 2024
Bank of Montreal (NYSE:BMO ) Q4 2024 Earnings Conference Call December 5, 2024 8:30 AM ET Company Participants Christine Viau - Head, Investor Relations Darryl White - Chief Executive Officer Tayfun T
BMO Financial Group Announces Intention to Repurchase Up to 20 Million of its Common Shares
06:02am, Thursday, 05'th Dec 2024
TORONTO , Dec. 5, 2024 /PRNewswire/ - Bank of Montreal (TSX:BMO)(NYSE:BMO) today announced its intention to purchase for cancellation up to 20 million of its common shares under a normal course issuer
